Clinical Trial Update: Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of MLN0264 in adults with advanced gastrointestinal cancers expressing guanylyl cyclase C has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• MLN0264

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Gastrointestinal Malignancies | Phase 1 | Status: COMPLETED | Results posted: 2016-07-25